​Maryland Maternal Opioid Misuse (MOM) Model

Background

The Maryland Department of Health (the Department) launched its Maternal Opioid Misuse (MOM) model in January 2020, with funding the Center for Medicare and Medicaid Innovation (CMMI) and in collaboration with the Centers for Medicare and Medicaid Services (CMS).  The model is a five-year, multi-pronged approach to combating the nation’s opioid crisis by addressing fragmentation in the care of pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD).
 
With over 21,000 individuals of childbearing age diagnosed with OUD in Maryland, substance use is a leading cause of maternal death and has significant impact on the approximately 1,500 infants born to Medicaid beneficiaries with OUD in Maryland per year. The MOM model focuses on improving clinical resources and enhancing care coordination to Medicaid beneficiaries with OUD during and after their pregnancies. 
 
Maryland is one of 10 states to secure funding for the MOM model. Between 2020 and 2024, the state will receive $3.6 million, with the opportunity to receive an additional $1.5 million based on achievement of performance targets. Maryland’s Medicaid program will work collaboratively with its nine managed care organizations (MCOs) and stakeholders to improve case management practices, bolster health information technology  and strengthen provider capacity throughout the state.

 

Resources and Information

For more information regarding the MOM Model and subawardees, please visit the following webpages.
 
Maryland’s MOM Model
 
Center for Medicare & Medicaid Innovation
CMMI’s MOM Model Webpage
 
 
 
Stakeholder Questions: Please direct comments, questions or suggestions regarding Maryland's Maternal Opioid Misuse Model to MDH.MOMModel@maryland.gov